Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01821352 · ClinicalTrials.gov registry record · NA

Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals

A NA study of Obesity, sponsored by Erchonia Corporation.

Completed
Registry status
NA
Development phase
53
Enrollment target
2
Study locations

NCT01821352 is a NA study of Obesity that has completed, run by Erchonia Corporation. The registered enrollment target is 53 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01821352, a NA study of Obesity, has completed, sponsored by Erchonia Corporation.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine whether low level laser light therapy is effective in reducing circumference of the waist, hips and upper abdomen in obese individuals.

Conditions Studied

Interventions

  • DEVICE Placebo Laser
  • DEVICE Erchonia Obesity Laser

Study Locations (2)

Indiana

  • Surgeons Inc. - Noblesville

Michigan

  • Bloomfield Laser and Cosmetic Surgery Center - Bloomfield Hills

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2013-03
Est. Completion 2014-04
Phase NA

Sponsor

Erchonia Corporation

34 total trials

What the Registry Record Tells You About NCT01821352

The ClinicalTrials.gov registry entry for NCT01821352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo Laser is the first listed.

NCT01821352 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Michigan.

Frequently Asked Questions

What is clinical trial NCT01821352 about?

NCT01821352 is a clinical study titled "Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals". The purpose of this study is to determine whether low level laser light therapy is effective in reducing circumference of the waist, hips and upper abdomen in obese individuals.

What is the current status of trial NCT01821352?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2013-03. Estimated completion is 2014-04.

What conditions does trial NCT01821352 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01821352?

The interventions under investigation include: Placebo Laser (DEVICE), Erchonia Obesity Laser (DEVICE).

Who is sponsoring clinical trial NCT01821352?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01821352 being conducted?

This trial has 2 study locations across Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.